These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33745898)

  • 1. Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial.
    Handberg EM; Merz CNB; Cooper-Dehoff RM; Wei J; Conlon M; Lo MC; Boden W; Frayne SM; Villines T; Spertus JA; Weintraub W; O'Malley P; Chaitman B; Shaw LJ; Budoff M; Rogatko A; Pepine CJ
    Am Heart J; 2021 Jul; 237():90-103. PubMed ID: 33745898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of risk profiles of participants in the Women's IschemiA TRial to Reduce events In non-ObstRuctive CAD (WARRIOR) trial, using Coronary Computed Tomography Angiography vs Invasive Coronary Angiography.
    Lakshmanan S; Wei J; Cook-Wiens G; Pepine CJ; Handberg EM; Shaw LJ; Budoff M; Merz CNB
    Prog Cardiovasc Dis; 2024; 84():90-93. PubMed ID: 38547955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease.
    Galway S; Adatia F; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Sep; 26(9):976-983. PubMed ID: 28384013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Secondary Prevention Medication on the Prognosis in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Abdu FA; Liu L; Mohammed AQ; Xu B; Yin G; Xu S; Xu Y; Che W
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):678-683. PubMed ID: 33284169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease.
    Adatia F; Galway S; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Nov; 26(11):1185-1192. PubMed ID: 28384014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.
    Sharaf B; Wood T; Shaw L; Johnson BD; Kelsey S; Anderson RD; Pepine CJ; Bairey Merz CN
    Am Heart J; 2013 Jul; 166(1):134-41. PubMed ID: 23816032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic Treatment of Patients With Myocardial Ischemia With No Obstructive Coronary Artery Disease.
    Turgeon RD; Pearson GJ; Graham MM
    Am J Cardiol; 2018 Apr; 121(7):888-895. PubMed ID: 29394999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "The INOCA-IT: Rationale and design of a multicenter registry investigating ischemia in patients with non-obstructive coronary artery (INOCA) disease in Italy".
    Ghizzoni G; Leone AM; di Serafino L; Galante D; Esposito G; Montorfano M; Chieffo A
    Int J Cardiol; 2024 May; 402():131859. PubMed ID: 38360100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study.
    Aldiwani H; Zaya M; Suppogu N; Quesada O; Johnson BD; Mehta PK; Shufelt C; Petersen J; Azarbal B; Samuels B; Anderson RD; Shaw LJ; Kar S; Handberg E; Kelsey SF; Pepine CJ; Bairey Merz CN
    J Am Heart Assoc; 2020 Feb; 9(4):e013168. PubMed ID: 32063125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
    Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-obstructive Plaque and Treatment of INOCA: More to Be Learned.
    Ya'Qoub L; Elgendy IY; Pepine CJ
    Curr Atheroscler Rep; 2022 Sep; 24(9):681-687. PubMed ID: 35781776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Medical Therapy and Lifestyle After Anatomical or Functional Testing for Coronary Artery Disease.
    Ladapo JA; Hoffmann U; Lee KL; Coles A; Huang M; Mark DB; Dolor RJ; Pelberg RA; Budoff M; Sigurdsson G; Severance HW; Douglas PS
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27733347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry.
    Steg PG; Greenlaw N; Tendera M; Tardif JC; Ferrari R; Al-Zaibag M; Dorian P; Hu D; Shalnova S; Sokn FJ; Ford I; Fox KM;
    JAMA Intern Med; 2014 Oct; 174(10):1651-9. PubMed ID: 25110899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia but no obstructive coronary artery disease: more than meets the eye.
    Patel N; Greene N; Guynn N; Sharma A; Toleva O; Mehta PK
    Climacteric; 2024 Feb; 27(1):22-31. PubMed ID: 38224068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Subclinical Coronary Artery Disease in Atrial Fibrillation Patients Identified by Coronary Computed Tomography Angiography.
    Nous FMA; Budde RPJ; van Dijkman ED; Musters PJ; Nieman K; Galema TW
    Am J Cardiol; 2020 Jul; 126():16-22. PubMed ID: 32345472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Practice Variations in the Management of Ischemia With No Obstructive Coronary Artery Disease.
    Luu JM; Wei J; Shufelt CL; Asif A; Tjoe B; Theriot P; Bairey Merz CN
    J Am Heart Assoc; 2022 Oct; 11(19):e022573. PubMed ID: 36172938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Lindahl B; Baron T; Erlinge D; Hadziosmanovic N; Nordenskjöld A; Gard A; Jernberg T
    Circulation; 2017 Apr; 135(16):1481-1489. PubMed ID: 28179398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Johnson BD; Shaw LJ; Buchthal SD; Bairey Merz CN; Kim HW; Scott KN; Doyle M; Olson MB; Pepine CJ; den Hollander J; Sharaf B; Rogers WJ; Mankad S; Forder JR; Kelsey SF; Pohost GM;
    Circulation; 2004 Jun; 109(24):2993-9. PubMed ID: 15197152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary Microvascular Dysfunction in Patients with Non-Obstructive Coronary Arteries: Current Gaps and Future Directions.
    Elgendy IY; Ya'Qoub L; Chen KH; Pepine CJ
    Drugs; 2022 Feb; 82(3):241-250. PubMed ID: 35092594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.